Idorsia Ltd
OTC: IDRSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jean-Paul Clozel
- Employees
- 1,100
- Headquarters
- Allschwil, Switzerland
- IPO year
- 2017
- Market cap
- $1.8B
- Website
- https://www.idorsia.com
Loading IDRSF…
Loading profile data…Frequently asked questions about IDRSF
What does Idorsia Ltd (IDRSF) do?
Established in 2017 and based in Allschwil, Switzerland, Idorsia Ltd operates as a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address significant unmet medical needs. The company's diverse clinical development pipeline targets various therapeutic areas, including central nervous syst...
Where does IDRSF trade?
Idorsia Ltd (IDRSF) trades on the Other OTC.
What sector is IDRSF in?
Idorsia Ltd (IDRSF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Idorsia Ltd?
Jean-Paul Clozel is the chief executive officer of Idorsia Ltd (IDRSF).
Where is Idorsia Ltd headquartered?
Idorsia Ltd is headquartered in Switzerland.
Does IDRSF pay a dividend?
Idorsia Ltd (IDRSF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IDRSF go public?
Idorsia Ltd (IDRSF) completed its initial public offering in 2017.